Pages that link to "Q37156650"
Jump to navigation
Jump to search
The following pages link to Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent (Q37156650):
Displaying 20 items.
- Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 Assays (Q27469990) (← links)
- Primer Sequence Modification Enhances Hepatitis C Virus Genotype Coverage (Q27470026) (← links)
- Broad Differences between the COBAS Ampliprep Total Nucleic Acid Isolation-COBAS TaqMan 48 Hepatitis C Virus (HCV) and COBAS HCV Monitor v2.0 Assays for Quantification of Serum HCV RNA of Non-1 Genotypes (Q27473157) (← links)
- Multilaboratory Comparison of Hepatitis C Virus Viral Load Assays (Q27473252) (← links)
- Comparison of Performance Characteristics of Three Real-Time Reverse Transcription-PCR Test Systems for Detection and Quantification of Hepatitis C Virus (Q27481004) (← links)
- Multicenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load Determination (Q27484906) (← links)
- Performance Characteristics of a Quantitative Hepatitis C Virus RNA Assay Using COBAS AmpliPrep Total Nucleic Acid Isolation and COBAS TaqMan Hepatitis C Virus Analyte-Specific Reagent (Q27485460) (← links)
- Anomalous Quantitation Standard Growth Curves in a Laboratory-Developed Hepatitis C Virus (HCV) RNA Quantification Assay Using the TaqMan HCV Analyte-Specific Reagent (Q27488880) (← links)
- Detection and Quantification of Hepatitis C Virus (HCV) by MultiCode-RTx Real-Time PCR Targeting the HCV 3' Untranslated Region (Q27489128) (← links)
- Occult infection with hepatitis C virus: friend or foe? (Q30416187) (← links)
- Interpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limits (Q34741602) (← links)
- Quantification of hepatitis B virus (HBV) DNA with a TaqMan HBV analyte-specific reagent following sample processing with the MagNA pure LC instrument (Q41824092) (← links)
- HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial (Q43001559) (← links)
- Discordance between HCV RNA Assays for Week 24 HCV RNA Determination during Pegylated Interferon-α/Ribavirin Treatment for Chronic Hepatitis C (Q43039486) (← links)
- Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders (Q43256130) (← links)
- Changes in sequences of core region, interferon sensitivity-determining region and interferon and ribavirin resistance-determining region of hepatitis C virus genotype 1 during interferon-alpha and ribavirin therapy, and efficacy of retreatment (Q45357130) (← links)
- High prevalence of hepatitis C virus infection in Airin district, Osaka, Japan: A hospital-based study of 1162 patients (Q45365442) (← links)
- Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response? (Q50569722) (← links)
- An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman (Q92354619) (← links)
- Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents (Q92481131) (← links)